Pages that link to "Q27472961"
Jump to navigation
Jump to search
The following pages link to Activation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA. (Q27472961):
Displaying 50 items.
- Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner (Q24319540) (← links)
- The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A (Q24632380) (← links)
- Diverse functions of RNase L and implications in pathology (Q24652347) (← links)
- Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response (Q24681387) (← links)
- Evidence for a functional RNA element in the hepatitis C virus core gene (Q24682695) (← links)
- The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response (Q26772138) (← links)
- Regulation of hepatic innate immunity by hepatitis C virus (Q26824743) (← links)
- Innate immune responses in hepatitis C virus infection (Q27023055) (← links)
- Coronavirus gene 7 counteracts host defenses and modulates virus virulence (Q27349527) (← links)
- Cell-free replication of the hepatitis C virus subgenomic replicon (Q27472942) (← links)
- Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA (Q27472970) (← links)
- RNase L plays a role in the antiviral response to West Nile virus (Q27473045) (← links)
- Viral Determinants of Resistance to Treatment in Patients with Hepatitis C (Q27478062) (← links)
- Hepatitis C virus RNA: Dinucleotide frequencies and cleavage by RNase L (Q27485064) (← links)
- The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy (Q27489040) (← links)
- Interferons at age 50: past, current and future impact on biomedicine (Q28259312) (← links)
- The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells (Q28513485) (← links)
- Evasion of intracellular host defence by hepatitis C virus (Q29618976) (← links)
- Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A (Q33714369) (← links)
- Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C (Q33898567) (← links)
- An interferon response gene signature is associated with the therapeutic response of hepatitis C patients (Q34027569) (← links)
- Quantitative analysis of interferon alpha receptor subunit 1 and suppressor of cytokine signaling 1 gene transcription in blood cells of patients with chronic hepatitis C. (Q34174547) (← links)
- Intracellular innate immune cascades and interferon defenses that control hepatitis C virus (Q34208090) (← links)
- RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP. (Q34210374) (← links)
- Liver x receptors regulate the transcriptional activity of the glucocorticoid receptor: implications for the carbohydrate metabolism. (Q34211621) (← links)
- Alphavirus minus-strand synthesis and persistence in mouse embryo fibroblasts derived from mice lacking RNase L and protein kinase R. (Q34466906) (← links)
- Evasion of antiviral innate immunity by Theiler's virus L* protein through direct inhibition of RNase L (Q34795484) (← links)
- Regulation of coronaviral poly(A) tail length during infection (Q34907070) (← links)
- The Quest for an Efficacious Antiviral for Respiratory Syncytial Virus (Q35115949) (← links)
- Is flavivirus resistance interferon type I-independent? (Q35129750) (← links)
- Functionally conserved architecture of hepatitis C virus RNA genomes (Q35229364) (← links)
- OASes and STING: adaptive evolution in concert (Q35569805) (← links)
- Hepatitis C Virus. Strategies to Evade Antiviral Responses (Q35604054) (← links)
- Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway (Q35689692) (← links)
- A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. (Q35857644) (← links)
- Pathologic effects of RNase-L dysregulation in immunity and proliferative control (Q36310770) (← links)
- Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection (Q36460968) (← links)
- Flying under the radar: the immunobiology of hepatitis C. (Q36635544) (← links)
- Interplay between viruses and host mRNA degradation (Q36785197) (← links)
- Interaction of hepatitis C virus with the type I interferon system (Q36935522) (← links)
- Treatment failure in hepatitis C: mechanisms of non-response. (Q37345286) (← links)
- Antagonism of RNase L Is Required for Murine Coronavirus Replication in Kupffer Cells and Liver Sinusoidal Endothelial Cells but Not in Hepatocytes. (Q37347335) (← links)
- Mechanisms of HCV survival in the host (Q37433774) (← links)
- Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro (Q37711751) (← links)
- Viruses and the cellular RNA decay machinery. (Q37940382) (← links)
- Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C. (Q38076757) (← links)
- Can't RIDD off viruses (Q38226271) (← links)
- Inhibition of the OAS/RNase L pathway by viruses (Q38558607) (← links)
- The influence of CpG and UpA dinucleotide frequencies on RNA virus replication and characterization of the innate cellular pathways underlying virus attenuation and enhanced replication. (Q38735720) (← links)
- Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection (Q39327457) (← links)